Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,911 | -43,513 | -29,896 | -18,841 | -7,802 |
| Depreciation Amortization | 280 | 1,001 | 723 | 373 | 70 |
| Accounts payable and accrued liabilities | -663 | 2,350 | 1,167 | 743 | 452 |
| Other Working Capital | -1,118 | 13,922 | 12,662 | 13,004 | -457 |
| Other Operating Activity | 1,507 | 420 | 821 | 512 | 147 |
| Operating Cash Flow | $-11,905 | $-25,820 | $-14,523 | $-4,209 | $-7,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -93 | -3,385 | -2,302 | -1,785 | -1,160 |
| Investing Cash Flow | $-93 | $-3,385 | $-2,302 | $-1,785 | $-1,160 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8 | 604 | 604 | 593 | 262 |
| Other Financing Activity | -2 | -245 | -241 | -146 | 0 |
| Financing Cash Flow | $6 | $359 | $363 | $447 | $262 |
| Beginning Cash Position | 46,076 | 74,922 | 74,922 | 74,922 | 74,922 |
| End Cash Position | 34,084 | 46,076 | 58,460 | 69,375 | 66,434 |
| Net Cash Flow | $-11,992 | $-28,846 | $-16,462 | $-5,547 | $-8,488 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,905 | -25,820 | -14,523 | -4,209 | -7,590 |
| Capital Expenditure | -93 | -3,385 | -2,302 | -1,785 | -1,160 |
| Free Cash Flow | -11,998 | -29,205 | -16,825 | -5,994 | -8,750 |